Loading clinical trials...
Loading clinical trials...
This is a pilot study to assess the safety, pharmacokinetics and effectiveness of PINTA 745 or placebo in treating protein energy wasting (PEW) in patients receiving maintenance hemodialysis (MHD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pinta Biotherapeutics
NCT07161037 · Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT07105670 · Chronic Kidney Disease Stage 3
NCT00001979 · Kidney Disease, Nephrotic Syndrome
NCT05398783 · Metabolic Disorders, Cancer, and more
DaVita Clinical Research
Lakewood, Colorado
Orlando Clinical Research Center
Orlando, Florida
DaVita Clinical Research
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions